Raymond James & Associates’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-35,138
| Closed | -$379K | – | 3779 |
|
|
2022
Q3 | $379K | Buy |
+35,138
| New | +$379K | ﹤0.01% | 3017 |
|
|
2021
Q1 | – | Sell |
-15,495
| Closed | -$391K | – | 3825 |
|
|
2020
Q4 | $391K | Buy |
15,495
+8,939
| +136% | +$226K | ﹤0.01% | 2954 |
|
|
2020
Q3 | $247K | Buy |
6,556
+580
| +10% | +$21.9K | ﹤0.01% | 3046 |
|
|
2020
Q2 | $256K | Buy |
+5,976
| New | +$256K | ﹤0.01% | 2987 |
|
|
2019
Q2 | – | Sell |
-42,000
| Closed | -$1.21M | – | 3503 |
|
|
2019
Q1 | $1.21M | Buy |
42,000
+17,000
| +68% | +$491K | ﹤0.01% | 2077 |
|
|
2018
Q4 | $673K | Buy |
+25,000
| New | +$673K | ﹤0.01% | 2335 |
|